Lung Microbiology

Anatomical Barriers to Infections

1. Mechanical Factors

  • Epithelial surfaces form a physical barrier that is highly impermeable to most infectious agents.
  • Skin serves as the first line of defense against invading organisms.
  • Desquamation (shedding) of skin epithelium also aids in removing bacteria and other infectious agents adhering to the epithelial surfaces.
  • Movement of cilia or peristalsis helps maintain air passages and the gastrointestinal tract free from microorganisms.
  • Flushing action of tears and saliva helps prevent infections of the eyes and mouth.
  • Mucus traps in the respiratory and gastrointestinal tracts provide protection for lungs and digestive systems against infection.

2. Chemical Factors

  • Fatty acids in sweat inhibit bacterial growth.
  • Lysozyme and phospholipase found in tears, saliva, and nasal secretions break down bacterial cell walls and destabilize membranes.
  • Low pH of sweat and gastric secretions prevents bacterial growth.
  • Defensins, low molecular weight proteins found in the lungs and gastrointestinal tract, exhibit antimicrobial activity.
  • Surfactants in the lungs function as opsonins which promote phagocytosis by phagocytic cells.

3. Biological Factors

  • Normal flora of the skin and gastrointestinal tract prevent colonization of pathogenic bacteria by secreting toxic substances and competing for nutrients or attachment to cell surfaces.

Lung Function

  • On average, a person breathes nearly 25,000 times daily, inhaling large volumes of air.
  • Airborne pollutants, such as bacteria, viruses, tobacco smoke, car exhaust, can result in lung disease and breathing difficulties.
  • Avoidance of pollution and effective clearance mechanisms are essential for healthy lung function.

Normal vs. Smokers’ Lungs

  • Difference in lung condition is visualized through comparative images of healthy lungs and smokers' lungs.

Anatomy of the Lungs

  • Main Structures:
    • Right main stem bronchus
    • Right lobes
    • Left main stem bronchus
    • Left lobes
    • Trachea
    • Bronchi
    • Bronchioles
    • Pleura
    • Pleural fluid
    • Diaphragm
    • Alveoli
  • Approximately 300 million alveoli are present, with a total surface area of about 140 m².

Clearance of Particles from Lungs

  • The lung has effective mechanisms for removing deposited particles.
  • Important particle clearance mechanisms include:
    • The mucociliary escalator
    • Coughing
    • Phagocytosis by alveolar macrophages.
  • Particle clearance is categorized as biphasic:
    • Fast clearance with a half-life of minutes to hours from the tracheobronchial area (mucociliary clearance).
    • Slow clearance with a half-life from days to thousands of days in the alveolar regions.
  • Therefore, the location of particle deposition affects both the mechanism and rate of clearance.

Mucociliary Function in Cystic Fibrosis (CF)

  • In non-CF airways, normal periciliary fluid depth allows for mucus islands to be propelled by ciliary movement toward the mouth.
  • In CF airways, mucus is poorly hydrated and hypoxic; compacted mucus inhibits ciliary movement.

Lung Tissue Comparisons

  • Lung tissue from cystic fibrosis patients shows extensive destruction due to obstruction and infection, contrasting with normal lung tissue.

Microbial Infections in Cystic Fibrosis

  • Shortly after birth, mucus in the bronchial tree of CF patients becomes stagnant, leading to early infections predominantly with:
    • Staphylococcus aureus
    • Haemophilus influenzae
  • Later infections (before 10 years of age) can include:
    • Pseudomonas aeruginosa
    • Co-infection with Burkholderia cepacia.

Pseudomonas aeruginosa

  • Characteristics:
    • Aerobic, motile, Gram-negative rod.
    • Capable of thriving in diverse environments, primarily found in water, soil, and vegetation.
    • Known for environmental versatility and ability to cause disease, along with resistance to antibiotics.
    • Serious complications in CF patients include respiratory tract infections and its role as an opportunistic pathogen in immunocompromised individuals (e.g., cancer and burn patients).
    • Known to cause various infections including ventilator-associated pneumonia, urinary infections, peritoneal dialysis catheter infections, bacterial keratitis, otitis externa, and burn wound infections.

Virulence Factors of Pseudomonas aeruginosa

  • Produces several toxic proteins regulated under quorum sensing (QS) that can cause extensive tissue damage and disrupt human immune defenses.
  • Key factors include:
    • Potent toxins that kill host cells at the infection site.
    • Degradative enzymes that disrupt cell membranes and connective tissue.
    • High alginate production contributes to biofilm formation in the lung, leading to chronic inflammatory responses.

Biofilms and Protection Mechanisms

  • Biofilms are composed of complex exopolysaccharides (slime) that provide adhesion and protection from macrophages, biocides, and antibiotics.

Intracellular Pathogens

  • These are pathogens that live and replicate within endosomal compartments or the cytosol of diverse host cells, including macrophages, dendritic cells, neutrophils, fibroblasts, epithelial cells, and erythrocytes.
  • All viruses are obligate intracellular pathogens; many bacterial pathogens also fall under this category, as do certain protozoa and fungi.

Macrophages and Clearance Mechanisms

  • Lung macrophages serve as a primitive defense system lacking mucociliary clearance.
  • Particles deposited in the lungs are cleared primarily by alveolar macrophages through phagocytosis.

Legionnaires’ Disease

  • Associated with symptoms linked to environmental exposure and underlying illnesses.

American Legionnaires Outbreak (1976)

  • Acute pneumonia outbreak among American veterans during a conference resulted in 221 pneumonia cases, with 34 deaths.
  • The causative agent, Legionella pneumophila, was identified.

Legionella-Associated Diseases

  • Legionnaires’ Disease
    • Acute fulminating pneumonia with a low attack rate and >12% fatality.
    • Notable outbreaks include those in Philadelphia (1976) and Stafford District Hospital, UK (1985).
  • Pontiac Fever
    • A mild, non-pneumonic febrile infection with a high attack rate and notable outbreaks such as in Pontiac County (1968, 1981).

Legionella Species Overview

  • The genus Legionellaceae has over 48 species, with the majority of cases (85%) attributed to L. pneumophila serogroup 1 (50%) and serogroup 6 (10%).
  • Other L. pneumophila serogroups account for 20%, while L. micdadei accounts for approximately 5% of cases.

Factors in Transmission

  • Legionella infection often involves inhalation of aerosolized droplets contaminated with bacteria from man-made water distribution systems.
  • Potential settings for outbreaks include warm storage tanks, air-conditioning systems, showers, whirlpool spas, and decorative fountains.
  • Certain outbreaks have also been connected to contaminated potting compost (e.g., L. longbeachae).

Survival Mechanisms of Legionella

  • Amoebal Symbiosis:
    • Legionella thrives within amoebae, providing protection against biocide treatments.
  • Improved survival in man-made water systems due to its resilience against high temperatures, low pH, and efficient reproduction in environments with nutrient sources like algae and bacteria.

Pathogenicity of Legionella pneumophila

  • Invades macrophages by triggering phagocytosis and establishes a replication-permissive vacuole that inhibits lysosome fusion.
  • Survival within the host is facilitated by the icm/dot genes responsible for intracellular multiplication and secretion.

Infection and Growth Dynamics

  • After macrophage engulfment, L. pneumophila remains in isolated phagosomes that merge with the endoplasmic reticulum rather than lysosomes, allowing replication while suppressing virulence traits.
  • Nutrient-rich environments within the phagosome enable the bacteria to thrive, with regulatory mechanisms dictating transitions for stationary phases and virulence trait expression for secondary infection transmission.

Mycobacterium tuberculosis

  • Identified as a weakly Gram-negative, strongly acid-fast aerobic rod with a slow doubling time (24-30 hours) characterized by a multi-lobate colony morphology.
  • Mycobacterial cell walls contain unique lipids such as mycolic acids that contribute to their resistance to antibiotics and biocides.

Pathogenicity and Spread of TB

  • Initial infection occurs through inhalation, with macrophages engulfing bacilli, leading to intracellular multiplication and granuloma formation.
  • Key characteristics of the bacterial lifecycle include the elicitation of immune responses (T-cell recruitment) and eventual granuloma formation that attempts to isolate the infection.
  • Factors regulating infection and immune System interplay fundamentally influence the course and outcome of TB, allowing M. tuberculosis to effectively evade host defenses.

Treatment and Control of Tuberculosis

  • TB control prioritizes the identification and treatment of active and latent infections.
  • Roughly 30% of the global population is estimated to be infected, primarily affecting the lungs.
  • Effective treatment regimens, including directly observed treatment short-course (DOTS) with drugs such as isoniazid and rifampin, tend to render patients non-infectious within two weeks of commencing treatment.
  • Comprehensive treatment regimens for active TB generally span six months.

Summary

  • The lungs face constant airborne challenges, but their defense mechanisms generally suffice for combating infections.
  • Healthy lung structure and function reduce susceptibility to both extracellular and intracellular pathogens, emphasizing the impact of lifestyle choices, such as smoking cessation, on respiratory health.
  • The evolution of pathogens to exploit immune evasion tactics (such as biofilm formation or intracellular predation) poses ongoing risks for lung infection.